The «COPD Assessment Test™» (CAT) quantifies the health impact of chronic obstructive pulmonary disease (COPD) and complements measurements such as one-second capacity (FEV1). CAT cannot be used to diagnose COPD. The questionnaire can be printed in english, german or french (via catestonline.org). «COPD Assessment Test™» is a trademark of the GlaxoSmithKline group of companies.
Recommendation:
Points | Health impact | Recommendation |
---|---|---|
5 | Upper limit of normal in healthy non- smokers. | |
< 10 | Low |
|
10-20 | Moderate |
Room for improvement:
|
20-30 | High |
Significant room for improvement:
|
> 30 | Very high |